cp-55,940 has been researched along with am 404 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernández-Ruiz, J; González, S; Lastres-Becker, I; López-Rodríguez, ML; Ortega-Gutiérrez, S; Ramos, JA; Viso, A | 1 |
| Fowler, CJ; Lambert, DM | 1 |
| Buonerba, M; Cascio, MG; Cavallo, P; De Martino, G; Di Marzo, V; Saturnino, C; Urbani, P | 1 |
| Chung, S; Dangott, LJ; Huang, H; Kier, AB; Landrock, D; Landrock, KK; Li, S; Martin, GG; McIntosh, AL; Schroeder, F | 1 |
1 review(s) available for cp-55,940 and am 404
| Article | Year |
|---|---|
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
Topics: Amides; Amidohydrolases; Amines; Animals; Arachidonic Acids; Binding Sites; Cannabinoid Receptor Modulators; Drug Design; Endocannabinoids; Esters; Ethers; Glycerides; Humans; Ligands; Monoacylglycerol Lipases; Polyunsaturated Alkamides; Receptors, Cannabinoid | 2005 |
3 other study(ies) available for cp-55,940 and am 404
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors.
Topics: Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Cannabinoids; Carrier Proteins; Cell Line; Cerebellum; Drug Design; Endocannabinoids; Furans; Humans; In Vitro Techniques; Membranes; Polyunsaturated Alkamides; Radioligand Assay; Receptors, Cannabinoid; Receptors, Drug; Spinal Cord; Structure-Activity Relationship | 2001 |
New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies.
Topics: Amides; Amidohydrolases; Arachidonic Acid; Arachidonic Acids; Cannabinoid Receptor Modulators; Cannabinoids; Cell Line; Chemistry, Pharmaceutical; Chromatography; Drug Design; Endocannabinoids; Fatty Acids; Humans; Inhibitory Concentration 50; Kinetics; Ligands; Models, Chemical; Polyunsaturated Alkamides; Protein Binding; Protein Structure, Tertiary; Receptors, Cannabinoid; Recombinant Proteins | 2006 |
FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein.
Topics: Animals; Endocannabinoids; Fatty Acid-Binding Proteins; Female; Fluorescent Dyes; Humans; Liver; Male; Mice; Mice, Inbred C57BL; Receptors, Cannabinoid | 2016 |